Addus HomeCare (NASDAQ:ADUS) Shares Down 6.1% – Here’s Why

Shares of Addus HomeCare Co. (NASDAQ:ADUSGet Free Report) traded down 6.1% during mid-day trading on Tuesday . The company traded as low as $117.27 and last traded at $121.10. 21,713 shares were traded during trading, a decline of 83% from the average session volume of 130,611 shares. The stock had previously closed at $128.96.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Macquarie reissued an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Monday. Stephens increased their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday. KeyCorp assumed coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. Oppenheimer raised their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Finally, Royal Bank of Canada dropped their price target on shares of Addus HomeCare from $141.00 to $136.00 and set an “outperform” rating on the stock in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average price target of $131.63.

Check Out Our Latest Stock Analysis on ADUS

Addus HomeCare Trading Up 5.5 %

The company’s 50-day simple moving average is $129.75 and its 200 day simple moving average is $120.92. The stock has a market cap of $2.37 billion, a P/E ratio of 29.97, a PEG ratio of 2.29 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The firm had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter last year, the firm earned $1.03 EPS. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. Research analysts anticipate that Addus HomeCare Co. will post 4.57 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the sale, the director now owns 3,866 shares in the company, valued at $502,695.98. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock valued at $3,050,082 in the last 90 days. 4.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in Addus HomeCare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after buying an additional 19,027 shares in the last quarter. Point72 Asset Management L.P. grew its stake in Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after buying an additional 315,602 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after buying an additional 5,421 shares in the last quarter. Principal Financial Group Inc. grew its stake in Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after buying an additional 75,409 shares in the last quarter. Finally, WCM Investment Management LLC grew its stake in Addus HomeCare by 2.9% in the 3rd quarter. WCM Investment Management LLC now owns 498,279 shares of the company’s stock valued at $65,250,000 after buying an additional 13,938 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.